Kurvelo for Irritability in Adolescents

(TeenVIBE Trial)

Not yet recruiting at 1 trial location
EA
ND
Overseen ByNatalie Deeb
Age: < 18
Sex: Female
Trial Phase: Phase 4
Sponsor: University of North Carolina, Chapel Hill
Must be taking: Oral contraceptives
Prior Safety DataThis treatment has passed at least one previous human trial

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores whether the birth control pill Kurvelo can reduce irritability and other mood issues in female adolescents at risk of suicide. Researchers focus on how hormonal changes affect mood during the menstrual cycle. Participants will take Kurvelo and a placebo (a pill with no active medicine) at different times to compare effects. Girls aged 12-16, who have started their periods and have moderate depressive symptoms, might be suitable if they can safely take birth control pills. As a Phase 4 trial, Kurvelo is already FDA-approved and proven effective, and this research aims to understand how it benefits more patients.

Do I have to stop taking my current medications for the trial?

The trial information does not specify if you need to stop taking your current medications. However, certain medications like Hepatitis C drug combinations are excluded, so it's best to discuss your specific medications with the trial team.

What is the safety track record for Kurvelo?

Research has shown that Kurvelo, a combination of two hormones, is generally safe and well-tolerated. In one study, 4.1% of users experienced nausea, and 3.6% reported headaches. These side effects are common but usually mild. Notably, only 11% of participants stopped using Kurvelo due to side effects, indicating that most people handle it well. Additionally, the FDA has approved Kurvelo for birth control, confirming its proven safety record.12345

Why are researchers enthusiastic about this study treatment?

Unlike the standard treatments for irritability in adolescents, which often involve behavioral therapy or medications like SSRIs (Selective Serotonin Reuptake Inhibitors), Kurvelo offers a unique approach by using a hormonal treatment. Kurvelo is a combined oral contraceptive containing ethinyl estradiol and levonorgestrel, which are synthetic hormones. Researchers are excited about this treatment because it targets irritability potentially linked to hormonal fluctuations, providing a novel angle compared to traditional methods. Additionally, its dual-phase structure—alternating between active treatment and placebo—allows researchers to better understand its specific effects on mood regulation.

What evidence suggests that Kurvelo might be an effective treatment for irritability in adolescents?

This trial will evaluate the effects of Kurvelo, a birth control pill containing estrogen and progestin, on mood and irritability in adolescents. Participants in one arm will receive Kurvelo first, followed by a placebo, while participants in the other arm will receive a placebo first, followed by Kurvelo. Studies have shown that hormonal changes, especially involving estrogen and progesterone, can affect mood and irritability in teenagers. Some research has found that teenagers using birth control pills like Kurvelo experienced improved moods. However, other studies have found a possible link between these pills and feelings of depression in some users. It's important to remember that everyone reacts differently, so while Kurvelo might improve mood for some, it might not have the same effect for everyone.14678

Who Is on the Research Team?

EA

Elizabeth Andersen, PhD

Principal Investigator

University of North Carolina, Chapel Hill

Are You a Good Fit for This Trial?

This trial is for girls aged 12-16 who have started their periods, are at risk of suicide due to moderate depression, and can safely take low-dose birth control pills. They must not have certain health conditions like blood clots, cancer, severe migraines, or major organ diseases.

Inclusion Criteria

I am able to take a low-dose birth control pill.
I have started having menstrual periods.
I was assigned female at birth.
See 2 more

Exclusion Criteria

Personal history of metabolic or autoimmune disease
I have epilepsy.
Known or suspected pregnancy
See 13 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment Phase 1: Kurvelo®

Participants receive 8 weeks of continuous combined oral contraceptive (COC; Kurvelo®: 30mcg ethinyl estradiol and 0.15mg levonorgestrel) to stabilize E2 and P4 levels.

8 weeks
Daily monitoring and one neuroimaging session

Washout

A 4-week washout period between treatment conditions.

4 weeks

Treatment Phase 2: Placebo

Participants receive 8 weeks of continuous placebo combined oral contraceptive pills.

8 weeks
Daily monitoring and one neuroimaging session

Follow-up

Participants are monitored for safety and effectiveness after treatment.

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Kurvelo
  • Placebo COC

Trial Overview

The study compares the effects of a continuous birth control pill (Kurvelo) versus a placebo on mood and brain changes in teenage girls with depressive symptoms. Each participant tries both treatments for 8 weeks each in random order with a break between them.

How Is the Trial Designed?

2

Treatment groups

Active Control

Placebo Group

Group I: Kurvelo®, then Placebo COCActive Control2 Interventions
Group II: Placebo COC, then Kurvelo®Placebo Group2 Interventions

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of North Carolina, Chapel Hill

Lead Sponsor

Trials
1,588
Recruited
4,364,000+

Foundation of Hope, North Carolina

Collaborator

Trials
18
Recruited
670+

Citations

Teen Vulnerability to Irritability: Brain and Estrogen Changes

Purpose: Risk of severe psychopathology increases dramatically during adolescence, especially for females. Changes in ovarian steroids ...

Association of Use of Oral Contraceptives With Depressive ...

In this cohort study of 1010 adolescents followed up for 9 years, 16-year-old oral contraceptive users showed higher concurrent depressive ...

Teen Vulnerability to Irritability: Brain and Estrogen Changes

Purpose: Risk of severe psychopathology increases dramatically during adolescence, especially for females. Changes in ovarian steroids ...

Oral contraceptives: side effects and depression in ...

We conducted a randomized trial of OCs for dysmenorrhea, which assessed side effects and depression. Seventy-six adolescents received an OC (20 μg of ...

Hormonal contraception and mood disorders - PMC - NIH

SUMMARY. Hormonal contraception is known to precipitate or perpetuate depression in some patients. The link between oral contraceptive pills ...

6.

pubmed.ncbi.nlm.nih.gov

pubmed.ncbi.nlm.nih.gov/12547661/

Adolescents' attitudes and experiences regarding ... - PubMed

Health care providers can assess adolescents' anticipated difficulties with compliance with daily pill taking, and desire for help from their parents.

(PDF) Efficacy, Safety, and Tolerability of a Levonorgestrel/ ...

Hormone-related treatment-emergent adverse events (TEAEs) included nausea (4.1%) and headache (3.6%); 11% of women discontinued due to AEs. Four women (all with ...

The Side Effects of Kurvelo (ETHINYL ESTRADIOL)

Comprehensive clinical review of Kurvelo side effects, detailing hormonal adverse reactions, venous thromboembolism risks, drug interactions ...